AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-76
Results: 1-25/76
CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/
Authors: URIUDA Y WANG QD HATORI N NORDLANDER R SJOQUIST PO MATTSSON C RYDEN L
Citation: Y. Uriuda et al., CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/, Journal of pharmacological and toxicological methods, 39(2), 1998, pp. 81-89
MYOCARDIOPROTECTIVE EFFECTS OF FELODIPINE IN AN ANTIHYPERTENSIVE DOSAGE - AN EXPERIMENTAL-STUDY IN PIGS
Authors: SHIMIZU M WANG QD SJOQUIST PO NORDLANDER R RYDEN L
Citation: M. Shimizu et al., MYOCARDIOPROTECTIVE EFFECTS OF FELODIPINE IN AN ANTIHYPERTENSIVE DOSAGE - AN EXPERIMENTAL-STUDY IN PIGS, Cardiovascular drugs and therapy, 12(1), 1998, pp. 37-45
THE LIPID-PEROXIDATION INHIBITOR INDENOINDOLE H290 51 PROTECTS MYOCARDIUM AT RISK OF INJURY-INDUCED BY ISCHEMIA-REPERFUSION/
Authors: SHIMIZU M WANG QD SJOQUIST PO RYDEN L
Citation: M. Shimizu et al., THE LIPID-PEROXIDATION INHIBITOR INDENOINDOLE H290 51 PROTECTS MYOCARDIUM AT RISK OF INJURY-INDUCED BY ISCHEMIA-REPERFUSION/, Free radical biology & medicine, 24(5), 1998, pp. 726-731
COAGULATION-FACTOR-V (ARG(506)-]GLN) MUTATION AND EARLY SAPHENOUS-VEIN GRAFT OCCLUSION AFTER CORONARY-ARTERY BYPASS-GRAFTING
Authors: MOOR E SILVEIRA A VANTHOOFT F TORNVALL P BLOMBACK M WIMAN B RYDEN L HAMSTEN A
Citation: E. Moor et al., COAGULATION-FACTOR-V (ARG(506)-]GLN) MUTATION AND EARLY SAPHENOUS-VEIN GRAFT OCCLUSION AFTER CORONARY-ARTERY BYPASS-GRAFTING, Thrombosis and haemostasis, 80(2), 1998, pp. 220-224
CALCIUM-ANTAGONISTS, APPROPRIATE THERAPY FOR DIABETIC-PATIENTS WITH HYPERTENSION
Authors: MALMBERG K RYDEN L WEDEL H
Citation: K. Malmberg et al., CALCIUM-ANTAGONISTS, APPROPRIATE THERAPY FOR DIABETIC-PATIENTS WITH HYPERTENSION, European heart journal, 19(9), 1998, pp. 1269-1272
RE-USED PACEMAKERS - AS SAFE AS NEW - A RETROSPECTIVE CASE-CONTROL STUDY (VOL 19, PG 154, 1998)
Authors: LINDE CL BOCRAY A JONSSON H ROSENQVIST N RADEGRAN K RYDEN L
Citation: Cl. Linde et al., RE-USED PACEMAKERS - AS SAFE AS NEW - A RETROSPECTIVE CASE-CONTROL STUDY (VOL 19, PG 154, 1998), European heart journal, 19(3), 1998, pp. 527-527
REUSE OF DEVICES IN CARDIOLOGY - PROCEEDINGS FROM A POLICY CONFERENCEAT THE EUROPEAN HEART HOUSE, 5-6 FEBRUARY, 1998
Authors: RYDEN L
Citation: L. Ryden, REUSE OF DEVICES IN CARDIOLOGY - PROCEEDINGS FROM A POLICY CONFERENCEAT THE EUROPEAN HEART HOUSE, 5-6 FEBRUARY, 1998, European heart journal, 19(11), 1998, pp. 1628-1631
SOCIAL-RELATIONS AND EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE -THE STOCKHOLM-FEMALE-CORONARY-RISK-STUDY
Authors: ORTHGOMER K HORSTEN M WAMALA SP MITTLEMAN MA KIRKEEIDE R SVANE B RYDEN L SCHENCKGUSTAFSSON K
Citation: K. Orthgomer et al., SOCIAL-RELATIONS AND EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE -THE STOCKHOLM-FEMALE-CORONARY-RISK-STUDY, European heart journal, 19(11), 1998, pp. 1648-1656
RE-USED PACEMAKERS - AS SAFE AS NEW - A RETROSPECTIVE CASE-CONTROL STUDY
Authors: LINDE CL BOCRAY A JONSSON H ROSENQVIST M RADEGRAN K RYDEN L
Citation: Cl. Linde et al., RE-USED PACEMAKERS - AS SAFE AS NEW - A RETROSPECTIVE CASE-CONTROL STUDY, European heart journal, 19(1), 1998, pp. 154-157
CONTINUOUS AMBULATORY HEMODYNAMIC MONITORING WITH AN IMPLANTABLE SYSTEM - THE FEASIBILITY OF A NEW TECHNIQUE
Authors: OHLSSON A NORDLANDER R BENNETT T BITKOVER C KJELLSTROM B LEE B RYDEN L
Citation: A. Ohlsson et al., CONTINUOUS AMBULATORY HEMODYNAMIC MONITORING WITH AN IMPLANTABLE SYSTEM - THE FEASIBILITY OF A NEW TECHNIQUE, European heart journal, 19(1), 1998, pp. 174-184
ANGIOTENSIN-II TYPE-1 RECEPTOR BLOCKADE WITH CANDESARTAN PROTECTS THEPORCINE MYOCARDIUM FROM REPERFUSION-INDUCED INJURY
Authors: SHIMIZU M WANG QD SJOQUIST PO RYDEN L
Citation: M. Shimizu et al., ANGIOTENSIN-II TYPE-1 RECEPTOR BLOCKADE WITH CANDESARTAN PROTECTS THEPORCINE MYOCARDIUM FROM REPERFUSION-INDUCED INJURY, Journal of cardiovascular pharmacology, 32(2), 1998, pp. 231-238
EFFECT OF INTENSE INSULIN-TREATMENT ON HYPERGLYCEMIA IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Authors: MALMBERG K NORHAMMAR A RYDEN L
Citation: K. Malmberg et al., EFFECT OF INTENSE INSULIN-TREATMENT ON HYPERGLYCEMIA IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Diabetologia, 41, 1998, pp. 159-159
THE IMPORTANCE OF ADMISSION PLASMA-GLUCOSE IN NONDIABETIC PATIENTS WITH MYOCARDIAL-INFARCTION
Authors: NORHAMMAR A RYDEN L MALMBERG K
Citation: A. Norhammar et al., THE IMPORTANCE OF ADMISSION PLASMA-GLUCOSE IN NONDIABETIC PATIENTS WITH MYOCARDIAL-INFARCTION, Diabetologia, 41, 1998, pp. 1320-1320
RISK MARKERS OF LONG-TERM OUTCOME IN PATIENTS WITH DIABETES AND ACUTEMYOCARDIAL-INFARCTION
Authors: RYDEN L NORHAMMAR A WEDEL H MALMBERG K
Citation: L. Ryden et al., RISK MARKERS OF LONG-TERM OUTCOME IN PATIENTS WITH DIABETES AND ACUTEMYOCARDIAL-INFARCTION, Diabetologia, 41, 1998, pp. 1324-1324
EXCELLENT TOLERABILITY OF HIGH-DOSES OF LISINOPRIL IN THE ATLAS TRIAL
Authors: MASSIE BM ARMSTRONG PW CLELAND JGF HOROWTIZ JJD PACKER M POOLEWILSON PA RYDEN L
Citation: Bm. Massie et al., EXCELLENT TOLERABILITY OF HIGH-DOSES OF LISINOPRIL IN THE ATLAS TRIAL, Circulation, 98(17), 1998, pp. 416-416
HEALTH ECONOMIC-BENEFITS OF TREATING PATIENTS WITH HEART-FAILURE WITHHIGH-DOSE LISINOPRIL VERSUS LOW-DOSE - THE ATLAS STUDY
Authors: CLELAND JGF MASSIE BM PACKER M ARMSTRONG PW HOROWITZ JD RYDEN L POOLEWILSON PA
Citation: Jgf. Cleland et al., HEALTH ECONOMIC-BENEFITS OF TREATING PATIENTS WITH HEART-FAILURE WITHHIGH-DOSE LISINOPRIL VERSUS LOW-DOSE - THE ATLAS STUDY, Circulation, 98(17), 1998, pp. 698-698
ISCHEMIA AS A TRIGGER FOR SUDDEN-DEATH IN PATIENTS WITH CARDIOMYOPATHY AND HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE - RESULTS FROM THE ATLAS TRIAL
Authors: URETSKY BF ARMSTRONG PW CLELAND JG HOROWITZ JD MASSIE BM RYDEN L PACKER M POOLEWILSON PA
Citation: Bf. Uretsky et al., ISCHEMIA AS A TRIGGER FOR SUDDEN-DEATH IN PATIENTS WITH CARDIOMYOPATHY AND HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE - RESULTS FROM THE ATLAS TRIAL, Circulation, 98(17), 1998, pp. 1031-1031
MARKERS OF RISK AFTER ACUTE MYOCARDIAL-INFARCTION - A COMPARISON OF CLINICAL-VARIABLES, AMBULATORY AND EXERCISE ELECTROCARDIOGRAPHY, ECHOCARDIOGRAPHY, AND STRESS ECHOCARDIOGRAPHY
Authors: QUINTANA M LINDVALL K BROLUND F STORCK N LINDBLAD LE RYDEN L
Citation: M. Quintana et al., MARKERS OF RISK AFTER ACUTE MYOCARDIAL-INFARCTION - A COMPARISON OF CLINICAL-VARIABLES, AMBULATORY AND EXERCISE ELECTROCARDIOGRAPHY, ECHOCARDIOGRAPHY, AND STRESS ECHOCARDIOGRAPHY, Coronary artery disease, 8(6), 1997, pp. 327-334
EXPERIENCE WITH AN IMPLANTABLE HEMODYNAMIC MONITOR IN THE LONG-TERM ASSESSMENT OF CONGESTIVE-HEART-FAILURE
Authors: CONNELLY DT STEINHAUS DM KUBO SH RYDEN L NORDLANDER R OHLSSON A BENNETT T STYLOS L CARDINAL D
Citation: Dt. Connelly et al., EXPERIENCE WITH AN IMPLANTABLE HEMODYNAMIC MONITOR IN THE LONG-TERM ASSESSMENT OF CONGESTIVE-HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 84143-84143
A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY
Authors: GRIP L FRISON L WALLENTIN L DELLBORG M GRANDE P HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K SLEIGHT P WILHELMSEN L NASLUND U GUNDERSEN T FISCHERHANSEN J LEHTO S BARRET M NILSSON JE TEGERNILSSON AC THORSEN M ANDERSEN F LUNDSTROM M HILDEBRAND A DEFLONOLSSON C FORSBY M ISBERG P LARSSON C NORGAARD B RASMUSSEN S VIDEBAEK J KLARLUND K LANDORPH A NIELSEN T AGNER E HOJGAARD MV HELQVIST S RASMUSSEN SL EGSTRUP K MYGIND L HANSEN JF SAJADIEH A GILL S HAGHFELT T MARKENVARD J THOMASSEN A JENSEN N PETERSEN J JENSEN G FISCHER T SIPILA R KIILAVUORI K HAMALAINEN L NURMINEN J MELIN J KOSKELA E HURME H VAUHONEN I HONKANEN T UTRIANEN S HAMALAINEN T LILJA M UKKOLVA O KIVELA H SODERSTROM S POHJOLASINTONEN S HUSSI E LARSEN A FALANG JE SCHARTUMHANSEN H PAULSEN A OMLAND T HOLM T EDVARDSEN T THYBO NK HAEREM J KAPELRUD H WAAGE K ROSSEBO B HAFSOY K HAMMARSTROM E ASTROM L HALL E WETTERVIK C FORSBERG SA TYGESEN H FREDRIKSSON B EKDAHL S KIHLSTROM K MAGNUSSON JO STJERNA A MARU F NILSSON H AKRAWI S SAETRE H AHLMARK G AHLBERG G LINDE B HAGSTROM L GUSTAFSSON G GUSTAVSSON PE LARSSON AC ANDERSEN K RUTER G KIERKEGAARD A HARDHAMMAR P KARLSSON JE SVENSSON O LANDGREN F HOLMBERG B RYDEN S WEINER L DANIELEWICZ M MALMROS B NICOL P JANZON M OHLIN H HANSEN O TINGBERG E NYMAN I FJELSTAD B AHLSTROM P HEDBACK B PERK J SVENNBERG L ELLSTROM J BOMAN K REMMETS J KRISTENSSON BE LINDER R HULTING J HOIJER J MOLLER BH LYCKSELL M WAHLIN M SANDSTEDT L REDFORS A BORRETZEN J OSTBERG G JOHANSSON B MORNER S LINDAHL B OLDGREN J JONSSON J NEMECZE K THORSEN S JOHANSSON PA SINNERSTAD B LARSSON LE BAND S MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425
PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - A RANDOMIZED CROSSOVER STUDY
Authors: KAPPENBERGER L LINDE C DAUBERT C MCKENNA W MEISEL E SADOUL N CHOJNOWSKA L GUIZE L GRAS D JEANRENAUD X RYDEN L GADLER F AEBISCHER N MABO P SLADE A ALIOT E MALECKA L LAVERGNE T MAURER B KULBERTUS H MAHAUX V SUTTON R KRANICH W
Citation: L. Kappenberger et al., PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - A RANDOMIZED CROSSOVER STUDY, European heart journal, 18(8), 1997, pp. 1249-1256
LONG-TERM EFFECTS OF DUAL-CHAMBER PACING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY WITHOUT OUTFLOW TRACT OBSTRUCTION AT REST
Authors: GADLER F LINDE C JUHLINDANNFELT A RIBEIRO A RYDEN L
Citation: F. Gadler et al., LONG-TERM EFFECTS OF DUAL-CHAMBER PACING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY WITHOUT OUTFLOW TRACT OBSTRUCTION AT REST, European heart journal, 18(4), 1997, pp. 636-642
RESTORATION OF ATRIAL FUNCTION AFTER THE MAZE PROCEDURE
Authors: DARPO B RYDEN L
Citation: B. Darpo et L. Ryden, RESTORATION OF ATRIAL FUNCTION AFTER THE MAZE PROCEDURE, European heart journal, 18(3), 1997, pp. 360-361
DISTRIBUTION OF KNOWLEDGE
Authors: RYDEN L POOLEWILSON P BREITHARDT G
Citation: L. Ryden et al., DISTRIBUTION OF KNOWLEDGE, European heart journal, 18(10), 1997, pp. 1523-1525
ONE-YEAR FOLLOW-UP AFTER RANDOMIZED PACING ON OFF TREATMENT FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM)/
Authors: KAPPENBERGER LL LINDE C DAUBERT C MCKENNA WJ MEISEL E SADOUL N CHOJNOWSKA L GUIZE L GRAS D JEANRENAUD X RYDEN L
Citation: Ll. Kappenberger et al., ONE-YEAR FOLLOW-UP AFTER RANDOMIZED PACING ON OFF TREATMENT FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM)/, Circulation, 96(8), 1997, pp. 2585-2585
Risultati: 1-25 | 26-50 | 51-75 | 76-76